These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


775 related items for PubMed ID: 16315138

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis.
    Muckenthaler M, Roy CN, Custodio AO, Miñana B, deGraaf J, Montross LK, Andrews NC, Hentze MW.
    Nat Genet; 2003 May; 34(1):102-7. PubMed ID: 12704390
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Clinicopathological study of Japanese patients with genetic iron overload syndromes.
    Hattori A, Miyajima H, Tomosugi N, Tatsumi Y, Hayashi H, Wakusawa S.
    Pathol Int; 2012 Sep; 62(9):612-8. PubMed ID: 22924847
    [Abstract] [Full Text] [Related]

  • 27. HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis.
    Shukla P, Julka S, Bhatia E, Shah S, Nagral A, Aggarwal R.
    Natl Med J India; 2006 Sep; 19(1):20-3. PubMed ID: 16570681
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin.
    Pietrangelo A.
    Gastroenterology; 2015 Oct; 149(5):1240-1251.e4. PubMed ID: 26164493
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Protective role of calreticulin in HFE hemochromatosis.
    Pinto JP, Ramos P, de Almeida SF, Oliveira S, Breda L, Michalak M, Porto G, Rivella S, de Sousa M.
    Free Radic Biol Med; 2008 Jan 01; 44(1):99-108. PubMed ID: 18045552
    [Abstract] [Full Text] [Related]

  • 33. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload.
    Wallace DF, Summerville L, Crampton EM, Frazer DM, Anderson GJ, Subramaniam VN.
    Hepatology; 2009 Dec 01; 50(6):1992-2000. PubMed ID: 19824072
    [Abstract] [Full Text] [Related]

  • 34. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
    Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, Miller A, McHugh PJ, Chapman RW, Pointon JJ, Wimhurst VL, Livesey KJ, Tanphaichitr V, Rochette J, Robson KJ.
    Hum Mol Genet; 2003 Sep 01; 12(17):2241-7. PubMed ID: 12915468
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Altered hepatic BMP signaling pathway in human HFE hemochromatosis.
    Bolondi G, Garuti C, Corradini E, Zoller H, Vogel W, Finkenstedt A, Babitt JL, Lin HY, Pietrangelo A.
    Blood Cells Mol Dis; 2010 Dec 15; 45(4):308-12. PubMed ID: 20863724
    [Abstract] [Full Text] [Related]

  • 37. Effects of alcohol consumption on iron metabolism in mice with hemochromatosis mutations.
    Flanagan JM, Peng H, Beutler E.
    Alcohol Clin Exp Res; 2007 Jan 15; 31(1):138-43. PubMed ID: 17207112
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 39.